(LJPC) |
| 0 (0%) 10-10 18:21 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 7.28 |
| Resistance 1: | 6.23 |
| Pivot price: | 6.22 |
| Support 1: | 6.21 |
| Support 2: | 6.20 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.292 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 16 May 2024
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs - Yahoo Finance
Mon, 22 Aug 2022
Innoviva Completes Acquisition of La Jolla Pharmaceutical - Business Wire
Mon, 11 Jul 2022
LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC - FinancialContent
Mon, 11 Jul 2022
Innoviva to Acquire La Jolla Pharmaceutical Company - citybiz
Mon, 11 Jul 2022
Innoviva to Acquire La Jolla Pharmaceutical Company - Business Wire
Mon, 11 Jul 2022
La Jolla Pharmaceutical (LJPC) Stock Skyrockets on Innoviva Acquisition News - InvestorPlace
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
